recurrent pregnancy loss. Spontaneous abortion
Conditions
Interventions
Intervention 1: Intervention: aspirin, 80mg, daily, two month before pregnancy and after pregnancy until 36 weeks of gestation, plus heparin, 5000unit twice a day after pregnancy until 4 weeks afte
Treatment - Drugs
Intervention: aspirin, 80mg, daily, two month before pregnancy and after pregnancy until 36 weeks of gestation, plus heparin, 5000unit twice a day after pregnancy until 4 weeks after delivery
Control: aspirin orally, 80mg, daily for two month before pregnancy and afte pregnancy until 36 weeks of gestation
Sponsors
Research and Clinical Center for Infertility,Yazd, Iran
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: unexplained recurrent pregnancy loss; women with thrombophilia exclusion criteria: abnormal karyotypes of each partner; uterine; cervical anatomical disorders on pelvic ultrasonography; hysteroscopy; abnormal ovaries function; abnormal endocrine tests; and antiphospholipid syndrome
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy after 20 weeks. Timepoint: after 20 weeks. Method of measurement: Sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Live-birth rates. Timepoint: 2 weeks after intervention. Method of measurement: mesearment of blood beta hCG. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasrin Ghasemi
Research and Clinical Center for Infertility, Yazd, Iran
Outcome results
None listed